Israeli-developed intelligent socks will help diabetics
January 27, 2016Diabetic neuropathy is a type of nerve damage associated with the development of foot ulcers in patients with diabetes. Resulting from anatomical deformation, excessive pressure and poor blood supply, it affects over 130 million individuals worldwide. It is also the leading cause of amputation, costing the United States economy alone more than $10 billion annually.
Diabetic patients are encouraged to get regular checkups to monitor for the increased pressure and ulceration that can eventually require amputation. However, ulcers are only diagnosed after they occur, meaning that patients require healing time, which dramatically increases healthcare costs.
Members of the BioDesign: Medical Innovation program, created by The Hebrew University of Jerusalem and its affiliated Hadassah Medical Center, set out to solve this problem.
“This is a significant medical problem that affects the lives of millions. We thought there must be a way to avoid these wounds altogether,” said Danny Bavli, the group’s lead engineer.
To address this challenge, Bavli partnered with Sagi Frishman and Dr. David Morgenstern, a leading orthopedic surgeon at Hadassah Medical Center. Together with other members of the Hebrew University BioDesign group, they developed SenseGO, a machine-washable sock containing dozens of micro-fabricated pressure sensors.
With SenseGO, changes in pressure due to incorrect posture, anatomical deformation or ill-fitting shoes are registered as electrical signals that are relayed to a smartphone app, which in turn informs the patient of developing risk.
Prof. Yaakov Nahmias, BioDesign program director, said: “This is a classic mobile health approach. By giving patients and their families the tools they need to prevent the development of ulcers, we can dramatically reduce health care costs related to diabetes.”
Other members of the BioDesign SenseGO team included Inbal Boxerman and Yael Hadar, MBA students at The Hebrew University of Jerusalem.
The innovations produced by the Biodesign program participants are commercialized by Yissum, the technology transfer company of the Hebrew University of Jerusalem, and Hadasit, the technology transfer company of the Hadassah Medical Center.
Similar posts
-
Dear World: I Don't Care
November 2, 2023By Avi Lewis I don’t care that you sympathize with Hamas I know you wouldn’t tolerate any of ...
-
Stand With Israel!
October 17, 2023Stand with Israel. Don't stand with the extreme terror organization Hamas. This is a war about huma...
-
Israel Thanks You For Your Support
October 13, 2023Israel extends its heartfelt gratitude to each and every one of you, dear friends and supporters, f...
-
How Israel Benefits the United States
October 5, 2023The relationship between Israel and the United States has been a cornerstone of American foreign po...
-
How Israel Helps Its Arab Neighbors
September 27, 2023Introduction Israel, a country known for its rich history and complex geopolitical landscape, ha...
-
The Amazing Country of Israel
September 15, 2023Introduction Nestled in the heart of the Middle East, Israel is a nation with a remarkable histo...
-
Israel Safeguards The World From Terror Attacks
August 23, 2023Introduction In an era where terrorism poses a significant threat to global security, Israel sta...
-
Israel Helps The World With Water Recycling
August 10, 2023Introduction In a world grappling with the challenges of water scarcity and resource management,...
where to buy such socks??